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INT ROD UCTION
It has long been kn own that obsessio ns and co mpu lsions occur during the
course of a sch izo phrenic illn ess (1- 7). It is, therefore , of interest that there has
bee n littl e syste matic r esearch into the treatment of these sym ptoms in pati ents
su ffering fro m sch izophrenia .
It is possible that the meager r esearch in this area is related both to the
difficulty at times in differentiating signs ofa psycho tic decompensation in severe
obsessive-compu lsive d isorder (OeD) fr om those of schizo phrenia; and to th e
significant amount of controversy regarding the function of obsessive co m pul-
sive symptoms in patients suffe r ing from sch izo ph renia and related di sea ses. For
examp le, Su llivan (3) was one of the first to note a relationship betwee n
sch izo phrenia and obsessive co mpulsive d isorder, and maintained that these
condi tions can sh ift from one to the o ther. O ver 30 years ago, Rose n (4) stu died
30 obsessive sch izop hren ics and observed that the obsessions emerged either
prior to , o r co ncom ita n t wit h , the schizop hren ic sym ptoms, and that non e of th e
patients had received psychi atric treatment p r io r to the schizophrenic decompen-
sat ion . T he implication is that obsessions were not taken as ser ious ly as th e
psychotic symp to ms even though they had p resaged serious illness. T his is
identical to one of th e cases we will prese nt.
Rosen 's study was simi lar to several o ther ea rly studies (5) , indicating th at
the associatio n between obsessive co mpulsive symptoms and schizophrenia is
rather frequent, wit h percenta ges varyi ng from 1% to 3.5 %, whil e more recent
stud ies (8) tend to indicate that over 10% of the schizophrenic patients p resent
significan t obsessive-co m pulsive symptoms.
T here has bee n sig nificant controversy, over the functi on of obsessive
symptoms in pat ie n ts suffering from sch izophrenia. In 1947 , Stengel (9) sug-
ge sted that obsessive co m pulsive phe nomena might prevent personali ty d isin te-
gration in schizo p hrenic pati ents. Rosen (4) a lso refer red to this associat ion an d
observed that th e d uratio n , e laboratio n and variety of obsessions were in versely
correlated with the se ver ity of sch izophrenic illness. In addition, he be lieved that
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th e presence of affective symptoms represented a good prognost ic sign in th ese
patients. Twenty five years after Rosen published hi s article, Fenton and Me-
Glas han (8) reported the results of their Chestnut Lodge fo llow-up study.
Contrary to the previously held co ncep ts, th ey concluded th at obsessive compul-
sive symp toms represented a poor prognosis in sch izophrenia. T hey compared
the funct ioning of a group of obsessive schizophrenics to a co ntrol group of
non-obsessive schizophrenics over a period of fifteen years, and observed signifi-
cantly lower funct ioning and more frequent hospitaliz ati ons in th e former
group. Insel and Akiskal (10) explain this discrepancy as resulting from the
difficu lt ies in clinically differentiating schizophrenic sympto ms from those of a
psychotic decompensa tio n in O CD . In fact, th ey felt that th e ea rlier authors
were at a disadvantage in lacking specific criteria such as th ose of DSM-III , as a
result of which some of the patients described as schizophrenic with obsessive
compulsive symptoms were in fact patients with severe OCD who had become
psyc hotic fo llowing a transient loss of insight. They consider th e progression of
OCD into schizophrenia to be extremely rare, and that suc h a psych ot ic picture
developing in a patient with O C D would be better clas sified as either a mood or a
delusional disorder.
Several ra ndom clin ica l observations while working in a partial hospital iza-
tion uni t tended to confirm the findings published by Fento n and McGl ash an.
Noting that some patients appeared to develop distressin g obsessions and or
compulsions in the early stages of a psychotic regression and that th is invari ably
led to hospitali zation , it was fel t that an attempt to remove th ese sympto ms by
uti lizing imi pramine might prevent the hospitalization , and cou ld result in no
more serious harm than co u ld be predicted if no treatment were attempted. The
following case reports detail our experiences in this approach .
CASE REPO RT S
Case 1
Mrs. A., a 32-year-old white female had previously been hospital ized on four
occasions since age 16, with the diagnosis of schizophrenia, pa ranoid type , characterized
by persecutory delusions and, consisting of the belief that both the FBI an d the Ma fia
were after her , auditory hall ucinations of her grandmother 's voice speaking to her. Her
father a lso had been treated for the same condition. Each of her acute decompensations
had been related to stressful events in her life (e.g. break-up of a love affa ir ; bir th of
daughter; placement of daughter in foster care); ea ch had been preceded by th e onset of
obsessive thoug hts. T hese consisted of perfectionistic ideas which increasingly made it
impossible for her to per form her daily routines, unti l finall y she be came co mplet ely
immobi lized. For example, prior to her first hospital ization she spe nt hours in th e show er
scrubbing her hands until they bled in an attempt to clean th em " perfec tly" . Pr ior to the
second hospitalization she failed her school exams because of her co mpulsion to study one
topic in such detail that she was unable to cover an assigned area . At no tim e in th e past
were these treated as specifically obsessions and compulsion s, but apparently were viewed
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as symptoma tic expressions of th e underlying schizophrenia. As a result, her only
treatment consiste d of neuroleptic medications (Ioxapine and tri fluoperazine) to which
she ea ch time responded sufficiently to leave the hospital each time. However, she
re ma ine d un employed for many yea rs, dur ing severa l of which she lived in a re sidence for
mentall y disabl ed persons. At the tim e of the present episode, she was living with he r
boyfri end and he r daughter, and attending th e partial hospital ization program at our
mental health center. After about a year in this program, she began to co mplain of the
co mpulsion to spend most of he r t ime in planning and maki ng no tes in preparation for
her dail y acti vities. Ultimately, she found hersel f unabl e to function, and grew increas-
ingly anxious, fearing an other psych otic decompensati on an d hospital ization. At the time
she was receiving trifluoperazine 10 mg h .s.; lorazep am 1 mg bid pm ; and benztropine 2
mg tid. We added imipramine to this regimen, rapidly increa sing the dose to 100
mg/day. After one week of treatment, the patient noted a decrease in the sever ity of her
co mpulsions, and afte r two weeks these sympto ms had subsided a lmost completely with
no evidence of det erioration in th e schizophrenic picture . T he pa tient remained stable
for three months of follow-up after which she was discharged from th e partial ho spitaliza -
tion program , on the medications described, with treatment continue d in the outpat ient
clinic.
Case 2
Mrs. B., a 29 -year-old d ivorced or thodox J ewish fema le had been hospitali zed on
four occasions with th e diagnosis of schizoa ffec tive d isorder. Each of the admission s
resulted from marked social withdrawal; disorganization of th oughts; paranoid de lusions,
and ultimately th e complete inability to care for herself. Her first psych otic dete rioration
occ ur red soon after sh e married, after which sh e grew increasingly isolat ed from famil y
and fr iends, and left her posit ion as a kindergarden teacher. She began to develop the
compulsion of hand washing after which she developed th e delu sion that her food was
poisoned. In spite of this she did not receive an y psychiatric int ervention for approxi-
mately two years, when , following childbirth , her symptoms grew so incapacitating that
she was taken to a psychiatrist who prescribed first clomipramine , and later an MAO!.
However, she grew increasingly psychotic and required hospital ization. While in th e
hospital her acute symptoms were somewhat controlled by lithium and neu roleptics, but
after discharge sh e was never able to return to her previous level of func tio ning, in spi te
of varied treatment effor ts, including trials of ca rbamazepine an d ECT. Whi le th e
differential diagnosis from paranoid schizoph re nia was a d ifficu lt one, it was felt th at a
diagnosis of schizoaffective disorder was more accurat e .
Shortly after her fourth hospitalization, whil e a patient in our partial hospitalization
service, she began again to demonstrate signs of withdrawal , developed a preoccupation
with sexual thoughts and spent most of the time in her room at the residence in which she
had lived for several years. Sh e was unable to mobilize herself to attend the sessions of th e
partial hospitalization unit. She was then re cei ving a combination of lith ium and a
thiothixene which had produced slight improvement in her symptom s in the past. It
appeared th at repeat ho spitalization was again immine nt, and in the face of this we felt
th at a trial of imipramine was in o rder. This was adde d to her regi men, and rapidly
increas ed to 150 mg/day. In two weeks she noted some decr ease in the severity of th e
sexual obsessions, and was abl e to resume her funct ioning in th e partial hospi talization
serv ice. At three month follow-up , she demonstrated no signs of psych o tic deterioration
and cont inued to attend the da y program in a regul ar fashion .
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Case 3
Mr. C., a 61-year-old married orthodox Jewish man was referred to our partial
hospitalization program because of severe obsessions, compulsion s, phobias, an d hypo-
chondriacal complaints which made it impossible for him to function . T his man had
never been hospitalized for psychiatric reasons, and had onl y one prio r psychiatric
contact, when, in his early twenties, he received outpatient therapy for several months,
because of "problems in finding a job." Although he had obtain ed high gra des in school ,
it remained difficult for him to find and keep a job, and for many yea rs he worked in a
very low-level position, retiring at age 50 because of a "heart co nd ition ." Although
medically stable, he never returned to work . He married in his thirt ies (rather lat e for a
man of his cu ltural background) explaining this as a result of his inability to support a
family. At the time of his referral to the partial hospitalization service, he resided with his
wife and two children. He had no other social contacts.
On admission to our service , the patient expressed concerns over cleanliness and
orderliness, and feared becoming infected. He engaged in hand-washing r itua ls, feared
contamination by touching a variety of objects in the house, and most speci fically, feared
that he had infected himself by " accident a lly pulling a hair out of his anal area while
taking a shower." He was quite anxious and appeared depressed. His speech was
circumstantial and tangential but there was no evidence of acute psychosis. He had
previously presented some sleep difficulties which were controlled by 5 mg diazepam
prescribed by his internist. He denied any suicidal ideations. T here were insufficient
indications for a diagnosis of major depressive disorder. MMPI testing was suggest ive of a
schizoid or schizotypal personality disorder, with a high score on the depressive sca le.
The final diagnosis was schizotypal personality disorder with obsessive co mpulsive symp-
toms.
He was treated for three months with supportive therapy in add ition to the previ-
ously mentioned diazepam), with no improvement noted. At this tim e he was given
imipramine, which was increased rapidly to 100 mg/day. After approximately two wee ks
the patient noted a decrease in his obsessions and phobias. After one month the
hand-washing rituals had disappeared, and the patient presented neither subjective
complaints, nor any signs of obsessions or phobias . After four months, he was tran sferred
to the outpatient clinic for continued supportive therapy in addition to th e imiprami ne
medication .
DISCUSSION
A survey of the litera ture reveals no systematic study of th e effects of
treating and removing obsessive compulsive symptoms whi ch present in the
course of a schizophrenic spectrum illness. There is even some controversy in
the literature, wit h some authors claiming that these symptoms tend to prevent
schizophrenic deterioration, and others noting that they tend to presage suc h
deterioration. Although the most recent study (10) supported the latter position ,
there appears to be a reluctance on the part of clinicians to attempt to treat these
symptoms with antidepressant medication. Perhaps this results from the concern
that this medication might worsen the psychosis (11-15).
In this pilot study, three patients with schizophrenic spectrum illn ess who
complained of severe obsessive compulsive symptoms we re treated with im i-
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pramine in addition to their ongoing medication regimen. T he imipramine was
rapidly increased to 100-150 mg/ day. In each case, a noticeable improvement
in the target symptoms was observed, with no psychotic deterioration occurring.
In fact, in two of the patients the obsessive compulsive symptoms had in previou s
episodes served as signals of impending deterioration and hospitali zati o n . In
these two patients removal of the symptoms permitted a restoration of func tion,
and the need for hospitalization was removed. All patients were fo llowed for at
least four months, and no recrudescence of symptoms or deterio rati on in
functioning was noted. Imipramine was chosen because at the time of the study
the tricyclic antidepressants, either alone or in combination with behavio r
therapy, provided the only widely accepted pharmacological approach to O C D
(16-24). Subsequent to the completion of this study clomipramine became
available in the United States. While ftuoxetine was available, its efficacy in
treating OCD was not ye t widely known.
It should be noted that the introduction of DSM-III-R has made co mpa rison
of earlier studies with more recent ones more difficult , since ma ny of the
conditions originally considered to be schizophrenia ha ve now bee n reclassified.
In a rather broad way the concept of "schizophrenic spectrum" illn esses encom-
passes both the DSM-III-R classification of schizophrenia and present DSM -III-
R diagnoses which formerly were considered to be sch izophrenia. T h is is the
term used to identify the patients presented in the following. While on ly one of
these met the DSM-III-R criteria for a diagnosis of schizophrenia , it is our
opinion that the other two patients, one with a diagnosis of schizoaffect ive
di sorder, and the other with that of schizotypal personality di sorder wo u ld each
have been considered schizophrenic by the earlier authors quoted .
In spite of the positive results obtained, we still cannot sta te definitely that
removal of obsessive compulsive symptoms in some sch izophrenics migh t not
lead to deterioration. Neither can we state with certainty that th e addition of
imipramine to ongoing neuroleptic medications will regularly lead to the allevia-
tion of these symptoms. However, given the positive results of this pilot clinica l
study, the authors are planning a structured research p rogram in hopes of
resolving remaining controversies in this area.
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